443.89 USD
▼-14.04-3.07%
盘后 445.66 +0.40%
2026-11-18
市值
$237.36B
市盈率
25.42
EPS
17.26
股息率
2.30%
52 周区间
312.39 – 483.99
成交量
2.59M
Beta
0.42
目标价
435.77
52W 低 312.3952W 高 483.99
价格走势

公司简介

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascul...

关联新闻